Julie Steenhusyens’s article, “As sequencing moves into clinical use, insurers balk,” examines the trend of some health insurers backing away from paying for certain types of genome sequencing, particularly when it is associated with trying to find a diagnosis for a rare or complex condition. The article highlights two success stories, Nic Volker and the Beery twins.
The NIH has created a primer on the issue of the clinical uses of genome analysis which may be of particular interest to physicians.